United States · FDA National Drug Code directory
MORPHINE SULFATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0406-8315_75047134-99f7-41cf-8088-88490e489074
- Product NDC
- 0406-8315
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- MORPHINE SULFATE
- Labeler
- SpecGx LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20030731
- Source listing expiry
- 20271231
Source-listed ingredients
- MORPHINE SULFATE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8315-01) · 0406-8315-01
- 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8315-23) · 0406-8315-23
- 100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8315-62) · 0406-8315-62
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →